In this episode, I dive into the latest diabetes tech and research from EASD 2024. We explore everything from all-in-one CGM and pump prototypes to an exciting dual-hormone pump used by 250 people, set to launch in 2026. I also take a closer look at the Kaliedo pump and its Diabeloop algorithm. Plus, I break down new research on how the Medtronic 780G with SmartGuard can benefit kids under 7, the importance of AID systems for pregnancy, and how CGMs are keeping people with type 2 diabetes out of the hospital.

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Watch Next:

Bi-Hormonal Pump from Beta Bionics

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

Why are so many endocrinologists burning out and leaving traditional medicine behind? Endo and artist Dr. Mike Natter shares an inside look at why many, including himself, are feeling overworked and exhausted. From grueling 70-hour work weeks to skipping meals and bathroom breaks, the pressure is relentless. Dr. Natter dives into the challenges of patient demands, endless paperwork, and the reality of being one of the lowest-paid medical specialties. We also explore why more endocrinologists are opting out of insurance and turning to concierge care and how he balances an industry focused on profits over patients, and his passion for helping people with the demands of a broken system.

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Follow Mike Natter

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

Trio, a new automated insulin delivery system built by the open-source community, has officially launched as an evolution of iAPS. Trio offers improvements with a focus on safety and community feedback. I’m joined by two key admins of Trio, to discuss its future advancements, including a sleek redesign, faster performance, and expanded caregiver functions. We also touch on how users are achieving over 80% time in range without needing to bolus before meals—showcasing just how transformative this system can be.

Find a Doctor on ZocDoc (today's sponsor)

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

More info on Trio

Listen: The Power of the iAPS Algorithm (still relevant!)

DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. Trio is experimental and not approved by the FDA or regulatory authorities at the time of this video. You take full responsibility for building and using Trio and you do so at your own risk. Results will vary.

I spoke with Veronica Elsea, who has been blind since birth, about her experiences using diabetes technology as a blind person. We also discuss how her organization, The Accessible Insulin Pump Task Force, is collaborating with the industry to make diabetes tech more accessible for the visually impaired community.

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Accessible Insulin Task Force Info

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

MARD (Mean Absolute Relative Difference) is often linked to continuous glucose monitor accuracy, but did you know there’s no universal standard for how companies measure it? In this episode, Tim Street from Diabettech dives into the lack of regulation in CGM clinical trials, revealing how manufacturers might manipulate MARD to appear more accurate.

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Follow Tim's Blog: Welcome to the Wild, Wild West: the CGM head-to-head study

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

CamAPS FX is the latest FDA cleared automated insulin delivery system for ages 2 and up, including during pregnancy. This app connects with a CGM and insulin pump to automate insulin delivery, simplifying diabetes management. Used in 17 European countries and expanding to New Zealand and Canada, CamAPS FX was developed by Dr. Roman Hovorka after 20 years of research at Cambridge University. Discover Dr. Hovorka's story and the impact of CamAPS FX in this episode.

Fill out T1D Exchange Registry (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

From longer wear times and more tubeless pump options to fully closed loop automated insulin systems, the future of insulin pumps looks bright. David Ahn and I dive into the innovations we’ll see in pump technology and what it all means.

Find a Doctor on ZocDoc (today's sponsor)

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Follow David Ahn here: Instagram | Tik Tok | X

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

CeQur Simplicity is an innovative insulin patch designed to function like traditional insulin injections. This device is applied directly to the user's body, delivering 2 units of insulin with each click through its cannula. It is intended for meal coverage and correction doses, complementing long-acting insulin. I had the opportunity to speak with CeQur's CEO to learn more about the device's functionality, its current user base, and future developments.

T1D Exchange Registry Sign up (US only)

Read the InPen ADA Abstraction

Join our Newsletter | Diabetech Community Discord

Join Patreon for Exclusive Content

Follow my other pages: Instagram | Tik Tok | YouTube | Facebook

DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.